| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 07/08/2009 | EP2076254A2 Combination with bis(thiohydrazide amides) for treating cancer |
| 07/08/2009 | EP1178830B1 Cyanine and indocyanine dye bioconjugates for biomedical applications |
| 07/07/2009 | US7556927 Methods for diagnosing, imaging and treating atherosclerotic disease |
| 07/01/2009 | EP2073845A2 Bioresorbable composition and a medical device comprising said composition |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/25/2009 | WO2009077908A1 Colloidal particle comprising multivalent cyclic anions |
| 06/25/2009 | US20090162293 Methods and compositions for ultrasound imaging of apoptosis |
| 06/25/2009 | US20090162281 Radionuclide labeling of Vitamin B12 and Co-enzymes thereof |
| 06/24/2009 | EP2072584A1 Phthalocyanine dyes, their preparation and use |
| 06/24/2009 | EP1983965A4 Photodynamic cosmetic procedure and healing method |
| 06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
| 06/23/2009 | US7550587 Photosensitizer and method for production thereof |
| 06/23/2009 | CA2346643C Model and method for inhibiting angiogenesis using photodynamic therapy |
| 06/18/2009 | WO2009075583A1 Use of particles comprising an alcohol |
| 06/18/2009 | WO2009074811A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 06/18/2009 | WO2009050571A3 Method of treatment of connective tissues and organs and uses of said tissues and organs |
| 06/18/2009 | US20090156463 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 06/18/2009 | CA2708137A1 Use |
| 06/17/2009 | EP2070544A2 Means of withdrawal from smoking |
| 06/17/2009 | EP2068940A2 Mri trackable drug delivery particles, uses and methods thereof |
| 06/17/2009 | EP1628958B1 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
| 06/17/2009 | CN101455841A Use of photochemical catalyst nano active water in healing uraemia |
| 06/16/2009 | US7547689 Motexafin gadolinium or lutetium for injection in sealed glass vial purged of oxygen; radiation sensitizer acts to catalyze the oxidation of NAD(P)H, ascorbate and other reducing agents |
| 06/11/2009 | WO2009072361A1 Composition for in vivo fluorescence test, method of testing breast cancer tissue using the same and method of imaging and observing diseased body tissue |
| 06/11/2009 | WO2009072079A2 Polymeric drug carrier for image-guided delivery |
| 06/10/2009 | EP2067485A1 Drug carrier providing MRI contrast enhancement |
| 06/10/2009 | EP2067484A2 Method for producing insulin in the form of an oral preparation |
| 06/10/2009 | EP1837032A4 Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions |
| 06/09/2009 | CA2481005C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 06/02/2009 | US7541457 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 05/28/2009 | WO2009067046A2 Method for producing polymer coating on particle surfaces |
| 05/28/2009 | WO2009066294A1 Device and method for photodynamic therapy |
| 05/27/2009 | EP2061512A1 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| 05/27/2009 | EP1509246B1 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 05/27/2009 | CN100491362C Biologically active methylene blue derivatives |
| 05/27/2009 | CN100490902C Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 05/27/2009 | CN100490812C Compisition as substitution of phthalocyanine cooperator and low density lipoprotein and its preparation process |
| 05/22/2009 | WO2009013630A3 Hyperthermia devices and their uses with nanoparticles |
| 05/22/2009 | WO2009000504A3 Injectable formulation for photodynamic therapy |
| 05/22/2009 | WO2008073851A3 Remotely triggered release from heatable surfaces |
| 05/20/2009 | CN101437489A Homeopathic composition and kit therefore |
| 05/20/2009 | CN100488965C Water soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 05/19/2009 | US7534773 reduces the expression of testosterone-repressed prostate message-2 provides therapeutic benefits in the treatment of cancer for example prostate cancer and renal cell cancer; Combined use with taxanes synergistically enhances cytotoxic chemosensitivity of androgen-independent prostate cancer |
| 05/14/2009 | WO2009060186A1 Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias |
| 05/13/2009 | EP2058007A2 Cyanine and indocyanine dye bioconjugates for biomedical applications |
| 05/13/2009 | EP2056878A2 Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules |
| 05/13/2009 | EP2056820A2 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof |
| 05/12/2009 | US7530940 Methods of enhancing radiation effects with metal nanoparticles |
| 05/12/2009 | US7530461 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 05/07/2009 | WO2008073856A3 Delivery of nanoparticles and/or agents to cells |
| 05/06/2009 | EP2054894A2 Composition apparatus and method for use in imaging |
| 05/06/2009 | EP2054030A1 Antimicrobials |
| 05/06/2009 | EP1583569A4 Ultrasonic catheter with axial energy field |
| 05/06/2009 | EP1521593B1 Transdermal botulinum toxin compositions |
| 05/06/2009 | EP1272193B1 Synergistic combination therapy for treating cancer |
| 05/06/2009 | CN100484520C 5-aminoketone valerate externally-applied preparation and production thereof |
| 04/29/2009 | EP2051699A2 Photosensitizer formulations for topical applications |
| 04/29/2009 | CN100482277C Calicheamicin derivative-carrier conjugates |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/28/2009 | CA2155833C Photodynamic treatment of synovium |
| 04/23/2009 | US20090105633 Ultrasound assembly for use with light activated drugs |
| 04/23/2009 | US20090104143 Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells |
| 04/22/2009 | EP2049664A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 04/22/2009 | CN101411720A Fungal medicinal granules for inducing suicide of cancer cell |
| 04/21/2009 | US7521551 Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy |
| 04/21/2009 | US7521239 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 04/16/2009 | WO2009048868A1 Photodynamic therapy process and photosensitizer compositions |
| 04/16/2009 | WO2009048532A2 Formation of particles for ultrasound application, drug release, and other uses, and microfluidic methods of preparation |
| 04/16/2009 | WO2006012359A3 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/16/2009 | CA2701764A1 Photodynamic therapy process and photosensitizer compositions |
| 04/15/2009 | EP2047866A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 04/15/2009 | EP1469891B1 Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
| 04/15/2009 | EP1100366B1 Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/09/2009 | WO2009045122A1 Medicinal agent for treating and preventing diabetes complications |
| 04/09/2009 | WO2008076333A3 Polymer-drug conjugates with tether groups for controlled drug delivery |
| 04/08/2009 | EP1409076A4 Method and apparatus for treating tumors using low strength electric fields |
| 04/07/2009 | US7514399 Use in tissue bonding and protein cross-linking and use in tissue and arterial repair, preservation of expanded internal luminal diameters, and local delivery of drugs, skin care materials, sunscreens, and cosmetics |
| 04/07/2009 | US7514069 Tumor-targeted optical contrast agents |
| 04/07/2009 | CA2451852C Contrast agents comprising metal particles encapsulated in microspheres for use in medical diagnostic imaging and therapy |
| 04/07/2009 | CA2312767C Drug delivery system with two-step targeting |
| 04/02/2009 | WO2009040811A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
| 04/02/2009 | WO2009040411A1 Photodynamic therapy and diagnosis using a chlorin e4 zinc complex |
| 04/01/2009 | EP2042194A2 Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 04/01/2009 | EP2040752A2 Core-shell nanoparticles for thearapy and imaging purposes |
| 03/31/2009 | US7511031 Transcutaneous photodynamic therapy; patch placed over target tissue; liposomal, transdermal, iontophoretic photosensitizing agent; light emitting diodes; atherosclerotic lesions and restenotic lesions |
| 03/31/2009 | US7510700 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 03/26/2009 | US20090081130 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
| 03/25/2009 | EP2037962A2 Method for introducing sirna into cells by photochemical internalisation |
| 03/25/2009 | EP2000150A9 Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle |
| 03/25/2009 | EP1380295B1 Photosensitiser and method for production thereof |
| 03/25/2009 | EP1353692B1 Methods and compositions for treatment of ocular neovascularization and neural injury |
| 03/24/2009 | CA2328136C Intramolecularly-quenched near infrared fluorescent probes |
| 03/19/2009 | US20090075253 Bioreactive agents |
| 03/18/2009 | EP2036550A1 Drug, drug induction device, magnetic detector and method of designing drug |
| 03/18/2009 | EP2034963A2 Gel-formulations of hydrophobic photosensitizers for mucosal applications |
| 03/17/2009 | US7504414 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/17/2009 | US7504087 Receptor-avid exogenous optical contrast and therapeutic agents |
| 03/17/2009 | CA2258882C Compositions and methods for altering the biodistribution of biological agents |